levetiracetam juno levetiracetam 500mg/100ml solution for infusion bags
horizon hospital healthcare pty ltd - levetiracetam -
levetiracetam juno levetiracetam 1500mg/100ml solution for infusion bags
horizon hospital healthcare pty ltd - levetiracetam -
levetiracetam juno levetiracetam 1000mg/100ml solution for infusion bags
horizon hospital healthcare pty ltd - levetiracetam -
levetiracetam horizon levetiracetam 1500mg/100ml solution for infusion bags
horizon hospital healthcare pty ltd - levetiracetam -
levetiracetam horizon levetiracetam 1000mg/100ml solution for infusion bags
horizon hospital healthcare pty ltd - levetiracetam -
levetiracetam horizon levetiracetam 500mg/100ml solution for infusion bags
horizon hospital healthcare pty ltd - levetiracetam -
erythromycin sxp erythromycin (as lactobionate) 1 g powder for injection vial
southern cross pharma pty ltd - erythromycin lactobionate -
ganciclovir sxp ganciclovir (as sodium) 500 mg powder for injection vial
southern cross pharma pty ltd - ganciclovir sodium, quantity: 546 mg (equivalent: ganciclovir, qty 500 mg) - injection, powder for - excipient ingredients: - ganciclovir sxp (ganciclovir) administered as the iv infusion is indicated for the palliative treatment of confirmed sight-threatening cytomegalovirus (cmv) disease in aids and other severely immunocompromised individuals. it is indicated for the treatment of confirmed cmv pneumonitis in bone marrow transplant patients. it is also indicated for the prophylaxis of cmv infection and disease following bone marrow and solid organ transplantation in patients at risk of cmv disease.,note: ganciclovir sxp (ganciclovir) is not indicated for congenital or neonatal cmv disease; nor for the treatment of cmv infection in non-immunocompromised individuals.
levetiracetam hhh levetiracetam 500mg/100ml solution for infusion bags
horizon hospital healthcare pty ltd - levetiracetam -
levetiracetam hhh levetiracetam 1500mg/100ml solution for infusion bags
horizon hospital healthcare pty ltd - levetiracetam -